493 related articles for article (PubMed ID: 25902915)
21. A distinct subset of atypical Spitz tumors is characterized by BRAF mutation and loss of BAP1 expression.
Wiesner T; Murali R; Fried I; Cerroni L; Busam K; Kutzner H; Bastian BC
Am J Surg Pathol; 2012 Jun; 36(6):818-30. PubMed ID: 22367297
[TBL] [Abstract][Full Text] [Related]
22. Clinical and dermoscopic features of cutaneous BAP1-inactivated melanocytic tumors: Results of a multicenter case-control study by the International Dermoscopy Society.
Yélamos O; Navarrete-Dechent C; Marchetti MA; Rogers T; Apalla Z; Bahadoran P; Blázquez-Sánchez N; Busam K; Carrera C; Dusza SW; de la Fouchardière A; Ferrara G; Gerami P; Kittler H; Lallas A; Malvehy J; Millán-Cayetano JF; Nelson KC; Quan VL; Puig S; Stevens H; Thomas L; Marghoob AA
J Am Acad Dermatol; 2019 Jun; 80(6):1585-1593. PubMed ID: 30244062
[TBL] [Abstract][Full Text] [Related]
23. Germline BAP1-positive patients: the dilemmas of cancer surveillance and a proposed interdisciplinary consensus monitoring strategy.
Star P; Goodwin A; Kapoor R; Conway RM; Long GV; Scolyer RA; Guitera P
Eur J Cancer; 2018 Mar; 92():48-53. PubMed ID: 29413689
[TBL] [Abstract][Full Text] [Related]
24. Occurrence of BAP1 germline mutations in cutaneous melanocytic tumors with loss of BAP1-expression: A pilot study.
Cabaret O; Perron E; Bressac-de Paillerets B; Soufir N; de la Fouchardière A
Genes Chromosomes Cancer; 2017 Sep; 56(9):691-694. PubMed ID: 28560743
[TBL] [Abstract][Full Text] [Related]
25. BAP1 deficiency causes loss of melanocytic cell identity in uveal melanoma.
Matatall KA; Agapova OA; Onken MD; Worley LA; Bowcock AM; Harbour JW
BMC Cancer; 2013 Aug; 13():371. PubMed ID: 23915344
[TBL] [Abstract][Full Text] [Related]
26. Two unique BAP1 pathogenic variants identified in the same family by panel cascade testing.
Byrne L; Ingalls C; Ansari A; Porteus C; Donenberg TR; Sussman DA; Cebulla CM; Abdel-Rahman MH
Fam Cancer; 2023 Jul; 22(3):307-311. PubMed ID: 36513904
[TBL] [Abstract][Full Text] [Related]
27. Germline BRCA1-associated protein 1 mutation presenting as BAP1 inactivated melanocytic nevi in a child of a father with fatal paraganglioma.
Watchorn RE; Calonje E; Taibjee SM
Pediatr Dermatol; 2018 Sep; 35(5):e316-e318. PubMed ID: 29974497
[TBL] [Abstract][Full Text] [Related]
28. Melanomas Associated With Blue Nevi or Mimicking Cellular Blue Nevi: Clinical, Pathologic, and Molecular Study of 11 Cases Displaying a High Frequency of GNA11 Mutations, BAP1 Expression Loss, and a Predilection for the Scalp.
Costa S; Byrne M; Pissaloux D; Haddad V; Paindavoine S; Thomas L; Aubin F; Lesimple T; Grange F; Bonniaud B; Mortier L; Mateus C; Dreno B; Balme B; Vergier B; de la Fouchardiere A
Am J Surg Pathol; 2016 Mar; 40(3):368-77. PubMed ID: 26645730
[TBL] [Abstract][Full Text] [Related]
29. Comparison of Germline versus Somatic BAP1 Mutations for Risk of Metastasis in Uveal Melanoma.
Ewens KG; Lalonde E; Richards-Yutz J; Shields CL; Ganguly A
BMC Cancer; 2018 Nov; 18(1):1172. PubMed ID: 30477459
[TBL] [Abstract][Full Text] [Related]
30. CDKN2A and BAP1 germline mutations predispose to melanoma and mesothelioma.
Betti M; Aspesi A; Biasi A; Casalone E; Ferrante D; Ogliara P; Gironi LC; Giorgione R; Farinelli P; Grosso F; Libener R; Rosato S; Turchetti D; Maffè A; Casadio C; Ascoli V; Dianzani C; Colombo E; Piccolini E; Pavesi M; Miccoli S; Mirabelli D; Bracco C; Righi L; Boldorini R; Papotti M; Matullo G; Magnani C; Pasini B; Dianzani I
Cancer Lett; 2016 Aug; 378(2):120-30. PubMed ID: 27181379
[TBL] [Abstract][Full Text] [Related]
31. Germline BAP1 mutation in a family with high incidence of multiple primary cancers and a potential gene-environment interaction.
Cheung M; Kadariya Y; Talarchek J; Pei J; Ohar JA; Kayaleh OR; Testa JR
Cancer Lett; 2015 Dec; 369(2):261-5. PubMed ID: 26409435
[TBL] [Abstract][Full Text] [Related]
32. BAP1-inactivated melanocytic tumor with preserved BAP1 expression? Morphology to the rescue!
Duncan LM; Tetzlaff MT
J Cutan Pathol; 2020 May; 47(5):459-461. PubMed ID: 32096236
[TBL] [Abstract][Full Text] [Related]
33. A population-based analysis of germline BAP1 mutations in melanoma.
O'Shea SJ; Robles-Espinoza CD; McLellan L; Harrigan J; Jacq X; Hewinson J; Iyer V; Merchant W; Elliott F; Harland M; Bishop DT; Newton-Bishop JA; Adams DJ
Hum Mol Genet; 2017 Feb; 26(4):717-728. PubMed ID: 28062663
[TBL] [Abstract][Full Text] [Related]
34. Assessment of Risk of Hereditary Predisposition in Patients With Melanoma and/or Mesothelioma and Renal Neoplasia.
Gupta S; Erickson LA; Lohse CM; Shen W; Pitel BA; Knight SM; Halling KC; Herrera-Hernandez L; Boorjian SA; Thompson RH; Leibovich BC; Jimenez RE; Cheville JC
JAMA Netw Open; 2021 Nov; 4(11):e2132615. PubMed ID: 34767027
[TBL] [Abstract][Full Text] [Related]
35. Difficult to Diagnose Cutaneous Melanoma in a Patient with BAP1 Tumor Predisposition Syndrome.
Silva-Clavería F; Álvarez-Muñoz A; Ferrándiz L; Fernández-Orland A; Conde-Martin AF; Moreno-Ramírez D; Ríos-Martín JJ
Int J Surg Pathol; 2023 Oct; 31(7):1398-1402. PubMed ID: 36803128
[TBL] [Abstract][Full Text] [Related]
36. The tumor suppressor BAP1 cooperates with BRAFV600E to promote tumor formation in cutaneous melanoma.
Webster JD; Pham TH; Wu X; Hughes NW; Li Z; Totpal K; Lee HJ; Calses PC; Chaurushiya MS; Stawiski EW; Modrusan Z; Chang MT; Tran C; Lee WP; Chalasani S; Hung J; Sharma N; Chan S; Hotzel K; Talevich E; Shain A; Xu M; Lill J; Dixit VM; Bastian BC; Dey A
Pigment Cell Melanoma Res; 2019 Mar; 32(2):269-279. PubMed ID: 30156010
[TBL] [Abstract][Full Text] [Related]
37. A novel BAP1 mutation is associated with melanocytic neoplasms and thyroid cancer.
McDonnell KJ; Gallanis GT; Heller KA; Melas M; Idos GE; Culver JO; Martin SE; Peng DH; Gruber SB
Cancer Genet; 2016 Mar; 209(3):75-81. PubMed ID: 26774355
[TBL] [Abstract][Full Text] [Related]
38. Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers.
Abdel-Rahman MH; Pilarski R; Cebulla CM; Massengill JB; Christopher BN; Boru G; Hovland P; Davidorf FH
J Med Genet; 2011 Dec; 48(12):856-9. PubMed ID: 21941004
[TBL] [Abstract][Full Text] [Related]
39. Ambiguous melanocytic tumors with loss of 3p21.
Yeh I; Mully TW; Wiesner T; Vemula SS; Mirza SA; Sparatta AJ; McCalmont TH; Bastian BC; LeBoit PE
Am J Surg Pathol; 2014 Aug; 38(8):1088-95. PubMed ID: 24705312
[TBL] [Abstract][Full Text] [Related]
40. Germline BAP1 inactivation is preferentially associated with metastatic ocular melanoma and cutaneous-ocular melanoma families.
Njauw CN; Kim I; Piris A; Gabree M; Taylor M; Lane AM; DeAngelis MM; Gragoudas E; Duncan LM; Tsao H
PLoS One; 2012; 7(4):e35295. PubMed ID: 22545102
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]